- Home
- Medications
- Zyloprim (Allopurinol) vs Alternatives: Comparison Guide
Zyloprim (Allopurinol) vs Alternatives: Comparison Guide
Zyloprim vs Gout Medication Alternatives
Zyloprim (Allopurinol)
Xanthine oxidase inhibitor
$10-20/monthFebuxostat
Xanthine oxidase inhibitor
$100-200/monthProbenecid
Uricosuric agent
$15-30/monthLesinurad
Urate reabsorption inhibitor
$500-800/monthPegloticase
IV uricase enzyme
$3,000-5,000/monthColchicine
Anti-inflammatory
$10-25/monthHow to Choose Your Medication
Consider these factors when selecting a gout medication:
- Kidney Function: Allopurinol and Febuxostat are affected by kidney function
- Cost: Probenecid and Colchicine are most affordable
- Effectiveness: Pegloticase provides highest reduction
- Side Effects: Allopurinol has rare but serious reactions
- Administration: Oral vs IV treatments
Detailed Medication Comparison
| Attribute | Zyloprim | Febuxostat | Probenecid | Lesinurad | Pegloticase |
|---|---|---|---|---|---|
| Mechanism | Xanthine oxidase inhibition | Xanthine oxidase inhibition | Increased excretion | Urate reabsorption inhibition | Uric acid conversion |
| Effectiveness | 30-40% reduction | 30-40% reduction | 20-30% reduction | 10-15% additional | Up to 90% reduction |
| Cost (Monthly) | $10-20 | $100-200 | $15-30 | $500-800 | $3,000-5,000 |
| Administration | Oral tablet | Oral tablet | Oral tablet | Oral tablet | IV infusion |
| Renal Impact | Dose adjustment needed | No dose adjustment | Normal kidney function | With xanthine oxidase inhibitor | Not applicable |
| Common Side Effects | Rash, DRESS syndrome | Liver enzyme elevation | Stomach upset | Increased kidney stones | Allergic reactions |
When doctors talk about long‑term gout control, Allopurinol usually tops the list. But it’s not the only option, and choosing the right drug depends on kidney health, cost, and how aggressively you need to lower uric acid. This guide breaks down Zyloprim (Allopurinol) side‑by‑side with the most common alternatives so you can see which one fits your needs.
Quick Summary
- Zyloprim (Allopurinol) is a xanthine oxidase inhibitor with decades of safety data.
- Febuxostat offers similar potency but can affect liver enzymes.
- Probenecid works by increasing uric acid excretion; good for mild‑to‑moderate gout.
- Lesinurad is used only with a urate‑lowering drug like Allopurinol.
- Pegloticase is an IV enzyme for refractory gout when oral meds fail.
What Is Zyloprim (Allopurinol)?
Zyloprim is the brand name for Allopurinol, a xanthine oxidase inhibitor that reduces the production of uric acid. First approved in the 1960s, it’s taken daily in doses ranging from 100mg to 800mg, adjusted for renal function. Typical patients see a 30‑40% drop in serum uric acid within 2‑4 weeks.
Because it blocks the enzyme that creates uric acid, Allopurinol is effective for both gout prevention and kidney‑related uric acid stones. The most common side effects are rash and, rarely, a severe hypersensitivity reaction called DRESS.
Key Alternatives at a Glance
Febuxostat is another xanthine oxidase inhibitor, approved in 2009. It’s metabolized mainly by the liver, so dosing isn’t limited by kidney function, but it can raise liver enzymes in about 5% of users.
Probenecid belongs to the uricosuric class. It blocks renal tubular reabsorption of uric acid, forcing more to exit in urine. It’s most useful when serum uric acid is only modestly elevated and kidney function is good.
Lesinurad is a selective uric acid reabsorption inhibitor that must be paired with a xanthine oxidase inhibitor (usually Allopurinol or Febuxostat). It adds about a 10‑15% extra reduction in uric acid.
Pegloticase is an intravenously administered recombinant uricase enzyme. It converts uric acid into allantoin, a highly soluble compound. It’s reserved for patients who have failed at least two oral therapies.
Colchicine isn’t a urate‑lowering drug; it’s used for acute gout flares and can be given low‑dose prophylactically when starting urate‑lowering therapy.
Comparing Mechanisms, Efficacy, and Safety
| Drug | Class | Primary Mechanism | Typical Dose | Uric‑Acid Reduction | Renal Considerations | Cost (US, 2025) |
|---|---|---|---|---|---|---|
| Zyloprim (Allopurinol) | Xanthine oxidase inhibitor | Blocks uric acid synthesis | 100‑800mg daily | 30‑40% | Dose reduced if eGFR<30mL/min | $0‑10/month (generic) |
| Febuxostat | Xanthine oxidase inhibitor | Blocks uric acid synthesis | 40‑80mg daily | 35‑45% | Safe down to eGFR<20mL/min | $120‑150/month |
| Probenecid | Uricosuric | Enhances renal excretion | 250‑500mg twice daily | 20‑30% | Contraindicated if eGFR<30mL/min | $30‑40/month |
| Lesinurad | Uric acid reabsorption inhibitor | Blocks URAT1 transporter | 200‑400mg daily (with XOI) | +10‑15% on top of XOI | Use with caution if eGFR<30mL/min | $250‑300/month |
| Pegloticase | Recombinant uricase | Converts uric acid to allantoin | 8mg IV infusion bi‑weekly | 70‑80% | Not cleared by kidneys; monitor for infusion reactions | $12,000‑14,000 per year |
When to Choose Allopurinol Over Others
If you have chronic gout, stable kidney function (eGFR≥30mL/min), and want a low‑cost option with a solid safety record, Allopurinol remains the go‑to. It works best when you need a steady 30‑40% uric‑acid drop and can tolerate a gradual dose increase.
Patients prone to liver issues often avoid Febuxostat, while those with severe renal impairment may need a lower dose of Allopurinol or switch to Febuxostat. For people who have failed two oral agents, Pegloticase becomes the rescue therapy.
Probenecid can be added when Allopurinol alone doesn’t hit target uric acid (<6mg/dL) and the kidneys are healthy. Lesinurad is only useful as an add‑on, not as monotherapy.
Decision Checklist for Your Doctor
- Assess kidney function (eGFR) - if below 30, consider Febuxostat or dose‑adjust Allopurinol.
- Check liver enzymes - if elevated, avoid Febuxostat.
- Determine target uric‑acid level - < 6mg/dL for most patients, <5mg/dL if tophi present.
- Review drug interactions - Allopurinol + azathioprine, mercaptopurine need dose‑reduction.
- Consider cost and insurance coverage - generic Allopurinol is typically $0‑10/month.
- Plan for flare prophylaxis - low‑dose colchicine or NSAIDs when starting any urate‑lowering drug.
- Evaluate need for rescue therapy - if two oral agents fail, discuss Pegloticase.
Potential Pitfalls and How to Avoid Them
Starting Allopurinol at a high dose can trigger gout flares. Begin with 100mg and uptitrate every 2‑4 weeks while using colchicine for prophylaxis. Also, never combine Allopurinol with high‑dose thiazide diuretics without monitoring uric acid, as they can blunt its effect.
Allergic skin reactions may appear within the first 6 weeks; if you notice a widespread rash, stop the drug immediately and contact your clinician. For patients on Lesinurad, watch for renal stones; stay well‑hydrated.
Frequently Asked Questions
Can I switch from Allopurinol to Febuxostat safely?
Yes, but the switch should be done under doctor supervision. Typically, you discontinue Allopurinol, allow a 2‑week washout, then start Febuxostat at 40mg. Monitor liver enzymes and uric acid for the first month.
Is Allopurinol safe during pregnancy?
Data are limited, but most guidelines consider Allopurinol a Category C drug. It’s only used if the benefit outweighs potential risks. Discuss alternatives with your OB‑GYN.
Why does my uric acid sometimes rise after starting Allopurinol?
Initial flare is common because existing urate crystals mobilize when serum levels drop. Prophylactic colchicine for the first 3‑6 months usually prevents painful attacks.
What’s the difference between uricosuric and xanthine oxidase inhibitors?
Uricosurics like Probenecid increase kidney excretion of uric acid, while xanthine oxidase inhibitors (Allopurinol, Febuxostat) block the enzyme that creates uric acid in the first place. Choice depends on kidney health and how much uric acid reduction you need.
Are there any natural supplements that can replace Allopurinol?
Cherries, vitamin C, and coffee have modest uric‑lowering effects, but they rarely achieve the 30‑40% drop needed for gout control. They can complement, not replace, prescription therapy.
Bottom line: Allopurinol remains a solid first‑line choice for most gout patients, especially when cost and renal function line up. Febuxostat, Probenecid, Lesinurad, and Pegloticase each fill specific niches-whether it’s liver‑friendly dosing, enhanced excretion, or rescue therapy. Talk to your doctor about labs, lifestyle, and insurance, then pick the regimen that keeps your uric acid low and your joints pain‑free.
- Oct 2, 2025
- DARREN LLOYD
- 1 Comments
- View posts
- permalink
Richard Sucgang
October 2, 2025 AT 15:08Allopurinol has a solid safety profile but you still need to watch the dose when kidneys are weak its rare DRESS reaction is a reminder that even cheap drugs can bite.